The above chart presents the market trend analysis for bhumi pharmaceuticals from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 177 transactions, with a transaction quantity of 1724588 and a transaction weight of 0.
YearTransactionsQuantityWeight
2025239498308840
202617717245880
Bill of lading data
<
1/15
>
Trade date
2026/02/21
B/L No.
5071807
Suppliers
bhumi pharmaceuticals
Buyers
sbr group of companies
POLs
ahmedabad
PODs
monrovia
Supply area
India
Purchas area
Liberia
Weight
——
Amount
151380.22
Hs code
30049099
Product tags
vitamin b complex,syrup,pharmaceuticals formulation,human,cyproheptadine
Product description
HUMAN PHARMACEUTICALS FORMULATION CYPROHEPTADINE WITH VITAMIN B COMPLEX SYRUP200ML
Expand
Trade date
2026/02/21
B/L No.
6012343
Suppliers
bhumi pharmaceuticals
Buyers
sbr group of companies
bhumi pharmaceuticals is india Supplier,
and primarily engages in the import and export business of products such as tablet,syrup,paracetamol.
According to the 52wmb.com global trade database, as of 2026-02-21, the company has completed 7804 international trades,
with its main trading regions covering liberia,guinea,angola etc.
The core products include HS30049099,HS30049029,HS30049039 etc,
often transported via bombay air,port ahmedabad icd, port ahemdabad icd insbi6 etc,
and its main trading partners are sbr group of companies,bunty pharmaceuticals,bunty farma.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on bhumi pharmaceuticals is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.